Literature DB >> 10873581

Possible role of calpain in normal processing of beta-amyloid precursor protein in human platelets.

M Chen1, J Durr, H L Fernandez.   

Abstract

Abnormal proteolytic processing of beta-amyloid precursor protein (APP) underlies the formation of amyloid plaques in aging and Alzheimer's disease. The proteases involved in the process have not been identified. Here we found that spontaneous proteolysis of intact APP in detergent-lysed human platelets generated a N-terminal fragment that was immunologically indistinguishable from secreted APP, reminiscent of the action of a putative alpha-secretase. This proteolysis of APP was inhibited by EDTA, suggesting that a metal-dependent protease was involved. Among the several metals tested, calcium was the only one that enhanced APP proteolysis and the reaction was blocked by EGTA as well as by several calpain inhibitors. The APP fragments generated by spontaneous proteolysis in platelet lysates were identical to those produced by exposure of partially purified APP to exogenous calpain. Finally, the secretion of APP from intact platelets was inhibited by cell-permeable calpain inhibitors. Taken together, these results suggest that normal processing of APP in human platelets is mediated by a calcium-dependent protease that exhibits calpain-like properties. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10873581     DOI: 10.1006/bbrc.2000.2919

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

Review 1.  Platelets and Alzheimer's disease: Potential of APP as a biomarker.

Authors:  Geneviève Evin; Qiao-Xin Li
Journal:  World J Psychiatry       Date:  2012-12-22

2.  Calpain activation promotes BACE1 expression, amyloid precursor protein processing, and amyloid plaque formation in a transgenic mouse model of Alzheimer disease.

Authors:  Bin Liang; Bao-Yu Duan; Xiu-Ping Zhou; Jia-Xin Gong; Zhen-Ge Luo
Journal:  J Biol Chem       Date:  2010-07-01       Impact factor: 5.157

3.  Trace copper levels in the drinking water, but not zinc or aluminum influence CNS Alzheimer-like pathology.

Authors:  D L Sparks; R Friedland; S Petanceska; B G Schreurs; J Shi; G Perry; M A Smith; A Sharma; S Derosa; C Ziolkowski; G Stankovic
Journal:  J Nutr Health Aging       Date:  2006 Jul-Aug       Impact factor: 4.075

Review 4.  Is the amyloid hypothesis of Alzheimer's disease therapeutically relevant?

Authors:  Andrew F Teich; Ottavio Arancio
Journal:  Biochem J       Date:  2012-09-01       Impact factor: 3.857

5.  Identification of small molecule inhibitors of beta-amyloid cytotoxicity through a cell-based high-throughput screening platform.

Authors:  K I Seyb; E R Schuman; J Ni; M M Huang; M L Michaelis; M A Glicksman
Journal:  J Biomol Screen       Date:  2008-09-23

6.  Cholesterol, copper, and accumulation of thioflavine S-reactive Alzheimer's-like amyloid beta in rabbit brain.

Authors:  D Larry Sparks
Journal:  J Mol Neurosci       Date:  2004       Impact factor: 3.444

7.  Inhibition of calpains improves memory and synaptic transmission in a mouse model of Alzheimer disease.

Authors:  Fabrizio Trinchese; Mauro Fa'; Shumin Liu; Hong Zhang; Ariel Hidalgo; Stephen D Schmidt; Hisako Yamaguchi; Narihiko Yoshii; Paul M Mathews; Ralph A Nixon; Ottavio Arancio
Journal:  J Clin Invest       Date:  2008-08       Impact factor: 14.808

8.  A new function of human HtrA2 as an amyloid-beta oligomerization inhibitor.

Authors:  Joel Kooistra; Julijana Milojevic; Giuseppe Melacini; Joaquin Ortega
Journal:  J Alzheimers Dis       Date:  2009       Impact factor: 4.472

9.  Our "energy-Ca(2+) signaling deficits" hypothesis and its explanatory potential for key features of Alzheimer's disease.

Authors:  Ming Chen; Huey T Nguyen
Journal:  Front Aging Neurosci       Date:  2014-12-03       Impact factor: 5.750

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.